12
Views
138
CrossRef citations to date
0
Altmetric
Research Article

Ligand-Induced Association of the Type I Interferon Receptor Components

, , &
Pages 4208-4214 | Received 29 Mar 1995, Accepted 19 May 1995, Published online: 30 Mar 2023
 

Abstract

Two transmembrane polypeptides, IFNAR and IFN-α/β R, were previously identified as essential components of the type I interferon (IFN) receptor, but their interrelationship and role in ligand binding were not clear. To study these issues, we stably expressed and characterized the two polypeptides in host murine cells. In human cells, native IFN-α/β R is a 102-kDa protein but upon reduction only a 51-kDa protein is detected. In host murine cells human IFN-α/β R was expressed as a 51-kDa protein. Host cells expressing IFN-α/β R bound IFN-α2 with a high affinity (Kd of 3.6 nM), whereas cells expressing IFNAR exhibited no ligand binding. Upon coexpression of IFNAR and the 51-kDa IFN-α/β R, the affinity for IFN-α2 was increased 10-fold, approaching that of the native receptor. We show by cross-linking that both the cloned (51-kDa) and native (102-kDa) IFN-α/β R bind IFN-α2 to form an intermediate product, while IFNAR associates with this product to form a ternary complex. Hence, IFNAR and IFN-α/β R are components of a common type I IFN receptor, cooperating in ligand binding. Ligand-induced association of IFNAR and IFN-α/β R probably triggers transmembrane signaling.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.